Clinical trials
Phase 1/2 Lymphoma, B-Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2019 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 2 |
| AstraZeneca | 1 |
| CRISPR Therapeutics AG | 1 |
| Cellectis S.A. | 1 |
| Daiichi Sankyo | 1 |
| Epizyme, Inc. | 1 |
| Gilead Sciences | 1 |
| Hoffmann-La Roche | 1 |
| Kite, A Gilead Company | 1 |
| Loxo Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 14 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Immune System Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Lymphatic Diseases | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.